1271 search results for:

CN Bio, a leading organ-on-a-chip (OOC) company that designs and manufactures single- and0 multi-organ microphysiological systems (MPS), has launched their PhysioMimix single-organ Higher Throughput (HT) system. The company’s first HT system has been designed to overcome adoption barriers currently limiting the use of predictive human liver models within drug discovery workflows, to enable use within […]

FUJIFILM Irvine Scientific, a world leader in the development and manufacture of serumfree and chemically defined cell culture media for bioproduction and cell therapy manu-facturing, has introduced its BalanCD HEK293 Viral Feed. The chemically defined, nutrient-based HEK293-specific feed medium is designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based […]

iotaSciences, a spin-out from Oxford University in the field of single-cell handling solutions has completed the development for its newly built single-cell picker instrumentation isoPick. isoPick represents a powerful addition to iotaSciences´ existing product portfolio for single-cell handling solutions based on its proprietary fluid-shaping technology. The product portfolio comprises instruments for automatic isolation, feeding and […]

MIMETAS, a leading company in the field of organ-on-a-chip-based disease models, has launched its Adult Stem Cell (ASC)-derived tubular organoids in an assay-ready format. As part of its OrganoReady product line, MIMETAS offers two organoid-based products: ASC-derived Colon and Kidney Organoid tubules.

Crimean-Congo haemorrhagic fever (CCHF) is a life-threatening tick-borne viral disease which is included in the World Health Organisation priorities for research and product development for early diagnostics. Since there is no CCHF vaccine available, management of outbreaks relies on rapid identification of cases and appropriate infection control measures.